Location History:
- Giessen, DE (1997)
- Ober-Morlen, DE (2000)
Company Filing History:
Years Active: 1997-2000
Title: The Innovations of Gert Muller-Berghaus
Introduction
Gert Muller-Berghaus, an accomplished inventor based in Ober-Morlen, Germany, has made significant contributions in the field of biomedical research. With a focus on advancements related to blood coagulation, his work is crucial for improving diagnostics and therapies related to thrombotic conditions.
Latest Patents
Muller-Berghaus holds two patents that exemplify his innovative spirit. The first patent details a method for the affinity-chromatographic purification of factor VIII, a critical component in blood coagulation. His second patent presents a method for determining lupus anticoagulant antibodies in blood, plasma, or tissue samples. This method involves measuring the inhibitory effect of lupus anticoagulant antibodies on the neutralizing effect of activated protein C. By determining the remaining levels of protein C activity after incubation with a defined amount of activated protein C, the amount of lupus anticoagulant antibodies can be quantified. This diagnostic method is vital for assessing a predisposition to thrombotic events and monitoring treatment efficacy.
Career Highlights
Muller-Berghaus has collaborated with prominent organizations in his career, notably working at Kerckhoff Klinik GmbH and the Max Planck Society for the Advancement of Science. His expertise and contributions in the field have been recognized and utilized in several innovative projects, making a lasting impact on blood coagulation research.
Collaborations
Throughout his career, Muller-Berghaus has worked closely with notable colleagues, including Bernd Potzsch and Horst Schwinn. These collaborations have facilitated advancements in their shared field, furthering the understanding and treatment of thrombotic diseases.
Conclusion
Gert Muller-Berghaus stands out as a significant inventor in the biomedical realm, with his patented methods offering valuable tools for diagnosing and managing blood coagulation disorders. His contributions, alongside his esteemed collaborations, highlight the importance of innovation in improving patient outcomes and advancing medical science.